Immunomodulatory agents in the laboratory and clinic
- 1 January 1992
- journal article
- review article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 105 (S1) , S5-S23
- https://doi.org/10.1017/s0031182000075326
Abstract
SUMMARY: This paper reviews naturally occurring and synthetic compounds that either enhance immune defences or lower both natural and acquired immunity. Immunomodulatory agents used both for laboratory study and clinically for the management of immunologically based diseases are consideredKeywords
This publication has 113 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- FACILITATION OF SPECIFIC TOLERANCE INDUCTION IN ADULT MICE BY RS-61443Transplantation, 1992
- Rapamycin: FK506's fraternal twin or distant cousin?Immunology Today, 1991
- PRECLINICAL EVALUATION OF A NEW POTENT IMMUNOSUPPRESSIVE AGENT, RAPAMYCINTransplantation, 1991
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- The acute phase protein response during parasitic infectionImmunology Today, 1991
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- FK-506 — How much potential?Immunology Today, 1989
- Inhibition of Histamine and Prostaglandin D2 Release from Human Lung Mast Cells by Ciclosporin AInternational Archives of Allergy and Immunology, 1989
- Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancerClinical Immunology and Immunopathology, 1986